Immunotherapy is becoming a larger part of the cancer community every day. Immunotherapy is a type of cancer treatment designed to boost the body’s natural defenses to fight the cancer. The body’s immune system will produce antibodies to fight off the cancer cells. Here at Charleston Hematology Oncology Associates, we offer many different clinical trials that contain immunotherapies as their primary concentration. For example: we have a trial that focuses on Opdivo (Nivolimab) and Yervoy (Ipilimumab) to specifically treat Non-Small Cell Lung Cancer first line. Typically these two drugs are used as second and third line therapies. To see if you qualify for this specific trial or for any of our other trials, please call 843-577-6957 to set up an appointment today.
What are Biosimilars?